Hytrin and Libido decreased - a phase IV clinical study of FDA data

Summary:

Libido decreased is reported as a side effect among people who take Hytrin (terazosin hydrochloride), especially for people who are male, 60+ old, have been taking the drug for 2 - 5 years also take Proscar, and have Prostatomegaly.

The phase IV clinical study analyzes which people have Libido decreased when taking Hytrin. It is created by eHealthMe based on reports of 7,298 people who have side effects when taking Hytrin from the FDA, and is updated regularly.

What is Hytrin?

Hytrin has active ingredients of terazosin hydrochloride. It is often used in prostate examination abnormal. eHealthMe is studying from 7,501 Hytrin users. Check the latest studies of Hytrin.

What is Libido decreased?

Libido decreased (loss of interest in sex) is found to be associated with 757 drugs and 910 conditions by eHealthMe. Check the latest studies of Libido decreased.

On Jul, 08, 2026

7,298 people reported to have side effects when taking Hytrin.
Among them, 32 people (0.44%) have Libido decreased.

Among these 32 people:

How long have people been on Hytrin when they have Libido decreased? *

What is the gender of people who have Libido decreased when taking Hytrin? *

female: 3.12 %
male: 96.88 %

What is the age of people who have Libido decreased when taking Hytrin? *

What are other drugs people take besides Hytrin? *

What are other side effects people have besides Libido decreased? *

Erection Problems: 14 people, 43.75%
Depression: 10 people, 31.25%
Weakness: 10 people, 31.25%
Fatigue (feeling of tiredness): 8 people, 25.00%
Gynecomastia (enlargement of the gland tissue of the male breast): 8 people, 25.00%
Stress And Anxiety: 7 people, 21.88%
Semen Volume Decreased: 7 people, 21.88%
Dyspnea (difficult or laboured breathing): 6 people, 18.75%
Emotional Distress: 5 people, 15.62%
Joint Pain: 4 people, 12.50%

What are the existing conditions these people have? *

Prostatomegaly (enlargement of the prostate): 5 people, 15.62%
Neuropathy Peripheral (surface nerve damage): 3 people, 9.38%
Muscle Aches (muscle pain): 3 people, 9.38%
Multiple Myeloma (cancer of the plasma cells): 3 people, 9.38%
Depression: 3 people, 9.38%
Bone Disorder: 3 people, 9.38%
Anaemia (lack of blood): 3 people, 9.38%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 6.25%
Asthma: 2 people, 6.25%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 1 person, 3.12%

* Approximation only. Some reports may have incomplete information.

Do you take Hytrin and have Libido decreased?

- Check whether Libido decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Hytrin:

Hytrin (7,501 reports)

Libido decreased treatments and more:

Libido decreased (16,674 reports)

Browse all side effects of Hytrin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Libido decreased:

Libido decreased (757 drugs)

Browse all the conditions that are associated with Libido decreased:

Libido decreased (910 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on terazosin hydrochloride (the active ingredients of Hytrin) and Hytrin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.